Lucia Lombardi

Imperial College London
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (8)

Year:

2025

Year:

2025

Year:

2025

De novo protein design has advanced such that many peptide assemblies and protein structures can be generated predictably and quickly. The drive now is to bring functions to these structures, for example, small-molecule binding and catalysis. The formidable challenge of binding and orienting multiple small molecules to direct chemistry is particularly important for paving the way to new functionalities. To address this, here we describe the design, characterization, and application of small-molecule:peptide ternary complexes in aqueous solution. This uses α-helical barrel (αHB) peptide assemblies, which comprise 5 or more α-helices arranged around central channels. These channels are solvent accessible, and their internal dimensions and chemistries can be altered predictably. Thus, αHBs are analogous to ‘molecular flasks’ made in supramolecular, polymer, and materials chemistry. Using Förster resonance energy transfer as a readout, we demonstrate that specific αHBs can accept two different organic dyes, 1,6-diphenyl-1,3,5-hexatriene and Nile Red in close proximity. In addition, two anthracene molecules can be accommodated within an αHB to promote photocatalytic anthracene-dimer formation. However, not all ternary complexes are productive, either in energy transfer or photocatalysis, illustrating the control that can be exerted by judicious choice and design of the αHB.

Year:

2025

This review explores the potential of peptide-based biomaterials to enhance biomedical applications through self-assembly, biological responsiveness, and selective targeting. Peptides are presented as versatile agents for antimicrobial activity and drug delivery, with recent approaches incorporating antimicrobial peptides into self-assembling systems to improve effectiveness and reduce resistance. The review also covers peptide-based nanocarriers for cancer drug delivery, highlighting their improved stability, targeted delivery, and reduced side effects. The focus of this work is on the bioactive properties of peptides, particularly in infection control and drug delivery, rather than on their structural design or material characteristics. Additionally, it examines the role of peptidomimetics in broadening biomaterial applications and enhancing resistance to enzymatic degradation. Finally, the review discusses the commercial prospects and challenges of translating peptide biomaterials into clinical applications.

Year:

2024

Self-assembling peptides have emerged as promising materials for pharmaceutical and biomedical applications due to their unique biocompatibility, biodegradability, and multifunctionality. These properties make them ideal candidates for addressing the challenges posed by biofilm-associated infections linked to implanted medical devices. Additionally, these peptides can form a variety of nanostructures, including nanotubes, hydrogels, and nanosheets, which facilitate targeted drug delivery and enhance therapeutic efficacy. The successful translation of peptide-based materials into clinical applications is exemplified by products like RADA16 and lanreotide, which improve therapeutic outcomes and enhance patient compliance. Furthermore, the development of peptidomimetics extends the versatility of these materials across various biomedical applications. This review highlights the potential of peptide-based biomaterials as effective tools in combating infections and as innovative platforms for drug delivery, emphasising their significance in modern medical therapies.

Year:

2024

Year:

2023

Year:

2023

Collaborators (9)

Nan Jiang

Professor

Sichuan University

CHINA
View details

Othman Al Musaimi

Lecturer

Imperial College London

UNITED KINGDOM
View details

Daryl R. Williams

-

UNITED KINGDOM
View details

Derek Woolfson

Academic , Professor of Chemistry and Biochemistry

University of Bristol

UNITED KINGDOM
View details

Guto Rhys

Lecturer (Asst. Prof) in Biological Chemistry

Cardiff University

UNITED KINGDOM
View details

David Scott

Chief Technology Officer

Rosa Biotech Limited

UNITED KINGDOM
View details

Freddie Martin

University of Bristol

UNITED KINGDOM
View details

Christopher Wood

Lecturer in Biotechnology

University of Edinburgh

UNITED KINGDOM
View details

Eleni Chatzilakou

Graduate Teaching Assistant

Imperial College London

UNITED KINGDOM
View details